Research on the link between expedited review and drug reevaluation from the perspective of innovation incentive based on the European Union's experienceYAN Jian-zhou, ZHANG Li-yang, LEI Lu-qian, SHAO Rong2921-2925
Research on quality risk identification and solutions of contract manufacturing under marketing authorization holder system:from the perspective of stakeholdersPAN Xiao-ying, MAO Ning-ying2926-2932
The inspiration of Certificate of Supplementary Protection (CSP)System in Canada to new drug research and development in ChinaDONG Lai-di, GU Dong-lei, ZHU Lin, LUO Ma, XU Kuo, Ouyang Ning2933-2938
Considerations on observation and measurement of efficacy variables in clinical trialsLIU Bing-lin, XUE Fei-ran2939-2947
Study on regulation of CYP450 enzyme system to reduce liver toxicity through the compatibility of radix aconiti lateralis praeparata with Panax ginseng C.A.Mey and Glycyrrhiza uralensis FischLI Han, ZHANG Guang-ping, MA Meng, SU Ping, YANG Yi-fei, CHEN Teng-fei, YE Zu-guang2948-2953
Progress of research and development of antibody-based therapeutics used for breast cancerWU Song-tao, ZHOU Shuang, XIE Ran, LUO Dao-huang, ZHAO Xia, ZHOU Ying, CUI Yi-min2954-2959
The pharmacotherapy and research progress of drugs for Alzheimer's diseaseWANG Xiao-zhen, WANG Rong2960-2964
Research progress in delivery of biological drugs by niosome-based drug delivery systemsWEI Xiao-qing, DAI Jing-ying, HE Lin2965-2968
Working principle of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) and its application in microbial researchFAN Xing-liang, CHEN Tian-you, LI Jing-yun, DUAN Kai2969-2973
Bioequivalence study of ticagrelor under fasting and fed conditions in Chinese healthy volunteersXIE Qiu-fen, XU Jun-yu, WANG Jie, WANG Chun-yan, ZHAO Xia, CHEN Ji, HE Shi-ying, CUI Yi-min2974-2980